{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:11:50Z","timestamp":1793797910329,"version":"4.6.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key R&D Program of China","award":["2018YFC1707000"],"award-info":[{"award-number":["2018YFC1707000"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973483"],"award-info":[{"award-number":["81973483"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673598"],"award-info":[{"award-number":["81673598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473349"],"award-info":[{"award-number":["81473349"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Natural Science Foundation of the Jiangsu Higher Education Institutions of China","award":["18KJB360008"],"award-info":[{"award-number":["18KJB360008"]}]},{"name":"National Standardization Program for Chinese Medicine","award":["ZYBZH-Y-SC-40"],"award-info":[{"award-number":["ZYBZH-Y-SC-40"]}]},{"name":"Special Fund for Research in the public interest","award":["201507002-2"],"award-info":[{"award-number":["201507002-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatic stellate cells (HSCs) were activated and secreted excessive amounts of extracellular matrix (ECM) proteins during pathogenetic progress of liver fibrosis. Germacrone (GMO) and miR-29b can play an important role in inhibiting growth of HSCs and production of type I collagen. GMO and miR-29b were co-encapsulated into nanoparticles (NPs) based on poly(ethylene glycol)-block-poly(lactide-co-glycolide) (PEG-PLGA). Then, NPs were modified with cyclic RGD peptides (cRGDfK). cRGDfK is an effective ligand to bind integrin \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub> and increase the targeting ability for fibrotic liver. GMO- and miR-29b-loaded NPs exhibited great cytotoxicity to activated HSCs and significantly inhibited production of type I collagen. Liver fibrosis model of mice was induced by administration of carbon tetrachloride. Great targeting ability was achieved in liver fibrotic mice treated with cRGD-modified NPs. Significant ant-fibrotic effects have been presented based on hematoxylin and eosin (H&amp;E), Masson and Sirius Red staining results of liver tissues collected from mice treated with drug-loaded NPs. All these results indicate GMO- and miR-29b-loaded cRGD-modified NPs have the potential for clinical use to treat liver fibrosis.<\/jats:p>","DOI":"10.1186\/s12951-020-00645-y","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T13:07:44Z","timestamp":1591621664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8810-946X","authenticated-orcid":false,"given":"De","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangjin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"645_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.addr.2017.10.011","volume":"121","author":"CL Wilson","year":"2017","unstructured":"Wilson CL, Mann DA, Borthwick LA. Epigenetic reprogramming in liver fibrosis and cancer. Adv Drug Deliv Rev. 2017;121:124\u201332.","journal-title":"Adv Drug Deliv Rev"},{"key":"645_CR2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/hepr.12674","volume":"46","author":"N Harimoto","year":"2016","unstructured":"Harimoto N, Yoshizumi T, Shimokawa M, Sakata K, Kimura K, Itoh S, Ikegami T, Ikeda T, Shirabe K, Maehara Y. Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70\u00a0years and older with hepatocellular carcinoma. Hepatol. Res. 2016;46:1247\u201355.","journal-title":"Hepatol. Res."},{"key":"645_CR3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/hepr.13333","volume":"49","author":"K Fujita","year":"2019","unstructured":"Fujita K, Oura K, Yoneyama H, Shi T, Takuma K, Nakahara M, Tadokoro T, Nomura T, Morishita A, Tsutsui K, Himoto T, Masaki T. Albumin\u2013bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C. Hepatol Res. 2019;49:731\u201342.","journal-title":"Hepatol Res."},{"key":"645_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-1236-z","volume":"10","author":"W Yoo","year":"2019","unstructured":"Yoo W, Lee J, Noh KH, Lee S, Jung D, Kabir MH, Park D, Lee C, Kwon KS, Kim JS, Kim S. Progranulin attenuates liver fibrosis by downregulating the inflammatory response. Cell Death Dis. 2019;10:1\u20132.","journal-title":"Cell Death Dis."},{"key":"645_CR5","doi-asserted-by":"publisher","first-page":"e3000563","DOI":"10.1371\/journal.pbio.3000563","volume":"17","author":"Z Wang","year":"2019","unstructured":"Wang Z, Cao D, Li C, Min L, Wang G. Mediator MED23 regulates inflammatory responses and liver fibrosis. PLoS Biol. 2019;17:e3000563.","journal-title":"PLoS Biol"},{"key":"645_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s10620-018-5311-1","volume":"64","author":"KC Lee","year":"2019","unstructured":"Lee KC, Hsu WF, Hsieh YC, Chan CC, Yang YY, Huang YH, Hou MC, Lin HC. Dabigatran reduces liver fibrosis in thioacetamide-injured rats. Dig Dis Sci. 2019;64:102\u201312.","journal-title":"Dig Dis Sci"},{"key":"645_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68\u201369","author":"E Roeb","year":"2018","unstructured":"Roeb E. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol. 2018;68\u201369:463\u201373.","journal-title":"Matrix Biol"},{"key":"645_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3390\/ijms20071723","volume":"20","author":"J Baglieri","year":"2019","unstructured":"Baglieri J, Brenner DA, Kisseleva T. The role of fibrosis and liver-associated fibroblasts in the pathogenesis of hepatocellular carcinoma. Int J Mol Sci. 2019;20:1723.","journal-title":"Int J Mol Sci."},{"key":"645_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2015.11.003","volume":"221","author":"TT Lin","year":"2016","unstructured":"Lin TT, Gao DY, Liu YC, Sung YC, Wan D, Liu JY, Chiang T, Wang L, Chen Y. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis. J Control Release. 2016;221:62\u201370.","journal-title":"J Control Release"},{"key":"645_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jconrel.2017.09.035","volume":"266","author":"NS El-Mezayen","year":"2017","unstructured":"El-Mezayen NS, El-Hadidy WF, El-Refaie WM, Shalaby TI, Khattab MM, El-Khatib AS. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: a novel strategy with potent efficacy in experimental liver fibrosis. J Control Release. 2017;266:226\u201337.","journal-title":"J Control Release"},{"key":"645_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.trsl.2019.07.007","volume":"214","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Lin CY, Cheng K. siRNA- and miRNA-based therapeutics for liver fibrosis. Transl Res. 2019;214:17\u201329.","journal-title":"Transl Res."},{"key":"645_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jconrel.2018.05.032","volume":"283","author":"J Bin Qiao","year":"2018","unstructured":"Bin Qiao J, Fan QQ, Xing L, Cui PF, He YJ, Zhu JC, Wang L, Pang T, Oh YK, Zhang C, Jiang HL. Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis. J Control Release. 2018;283:113\u201325.","journal-title":"J Control Release."},{"key":"645_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejphar.2012.10.013","volume":"698","author":"Y Liu","year":"2013","unstructured":"Liu Y, Wang W, Fang B, Ma F, Zheng Q, Deng P, Zhao S, Chen M, Yang G, He G. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2\/M cell cycle arrest and promoting apoptosis. Eur J Pharmacol. 2013;698:95\u2013102.","journal-title":"Eur J Pharmacol"},{"key":"645_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jchromb.2015.12.024","volume":"1026","author":"Q Dong","year":"2016","unstructured":"Dong Q, Qiu LL, Zhang CE, Chen LH, Feng WW, Ma LN, Yan D, Niu M, Wang JB, Xiao XH. Identification of compounds in an anti-fibrosis Chinese medicine (Fufang Biejia Ruangan Pill) and its absorbed components in rat biofluids and liver by UPLC-MS. J Chromatogr B Anal Technol Biomed Life Sci. 2016;1026:145\u201351.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci."},{"key":"645_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.addr.2018.01.009","volume":"129","author":"Q Su","year":"2018","unstructured":"Su Q, Kumar V, Sud N, Mahato RI. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis. Adv Drug Deliv Rev. 2018;129:54\u201363.","journal-title":"Adv Drug Deliv Rev"},{"key":"645_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bbrc.2011.07.041","volume":"412","author":"Y Sekiya","year":"2011","unstructured":"Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun. 2011;412:74\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"645_CR17","doi-asserted-by":"publisher","first-page":"7325","DOI":"10.18632\/oncotarget.2621","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, Chu ESH, Chen HY, Man K, Go MYY, Huang XR, et al. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway. Oncotarget. 2015;6:7325\u201338.","journal-title":"Oncotarget."},{"key":"645_CR18","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1016\/j.cellsig.2012.07.023","volume":"24","author":"Y He","year":"2012","unstructured":"He Y, Huang C, peng Zhang S, Sun X, ran Long X, Li J. The potential of microRNAs in liver fibrosis. Cell Signal. 2012;24:2268\u201372.","journal-title":"Cell Signal."},{"key":"645_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.bbrc.2009.11.056","volume":"391","author":"T Ogawa","year":"2010","unstructured":"Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. 2010;391:316\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"645_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.colsurfb.2018.05.012","volume":"169","author":"Q Chen","year":"2018","unstructured":"Chen Q, Gou S, Huang Y, Zhou X, Li Q, Han MK, Kang Y, Xiao B. Facile fabrication of bowl-shaped microparticles for oral curcumin delivery to ulcerative colitis tissue. Colloids Surfaces B Biointerfaces. 2018;169:92\u20138.","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"645_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jconrel.2018.04.016","volume":"279","author":"B Tang","year":"2018","unstructured":"Tang B, Zaro JL, Shen Y, Chen Q, Yu Y, Sun P, Wang Y, Shen WC, Tu J, Sun C. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting. J Control Release. 2018;279:147\u201356.","journal-title":"J Control Release"},{"key":"645_CR22","first-page":"2334","volume":"2017","author":"M Dowaidar","year":"1861","unstructured":"Dowaidar M, Abdelhamid HN, H\u00e4llbrink M, Zou X, Langel \u00dc. Graphene oxide nanosheets in complex with cell penetrating peptides for oligonucleotides delivery. Biochim. Biophys. Acta-Gen. Subj. 1861;2017:2334\u201341.","journal-title":"Biochim. Biophys. Acta-Gen. Subj."},{"key":"645_CR23","doi-asserted-by":"publisher","first-page":"11939","DOI":"10.1016\/j.biomaterials.2019.119393","volume":"219","author":"Y Ji","year":"2019","unstructured":"Ji Y, Lu F, Hu W, Zhao H, Tang Y, Li B, Hu X, Li X, Lu X, Fan Q, Huang W. Tandem activated photodynamic and chemotherapy: Using pH-Sensitive nanosystems to realize different tumour distributions of photosensitizer\/prodrug for amplified combination therapy. Biomaterials. 2019;219:11939.","journal-title":"Biomaterials."},{"key":"645_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.actbio.2019.03.056","volume":"90","author":"Q Yang","year":"2019","unstructured":"Yang Q, Li P, Ran H, Wan J, Chen H, Chen H, Wang Z, Zhang L. Polypyrrole-coated phase-change liquid perfluorocarbon nanoparticles for the visualized photothermal-chemotherapy of breast cancer. Acta Biomater. 2019;90:337\u201349.","journal-title":"Acta Biomater"},{"key":"645_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.carbpol.2018.09.020","volume":"203","author":"Y Mu","year":"2019","unstructured":"Mu Y, Fu Y, Li J, Yu X, Li Y, Wang Y, Wu X, Zhang K, Kong M, Feng C, Chen X. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug. Carbohydr Polym. 2019;203:10\u20138.","journal-title":"Carbohydr Polym"},{"key":"645_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s12274-019-2330-y","volume":"12","author":"Y Li","year":"2019","unstructured":"Li Y, Hu J, Liu X, Liu Y, Lv S, Dang J, Ji Y, He J, Yin L. Photodynamic therapy-triggered on-demand drug release from ROS-responsive core-cross-linked micelles toward synergistic anti-cancer treatment. Nano Res. 2019;12:999\u20131008.","journal-title":"Nano Res."},{"key":"645_CR27","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1039\/C7BM00392G","volume":"5","author":"J Dang","year":"2017","unstructured":"Dang J, He H, Chen D, Yin L. Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT). Biomater Sci. 2017;5:1500\u201311.","journal-title":"Biomater Sci."},{"key":"645_CR28","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1021\/acsnano.5b07882","volume":"16","author":"Y Yang","year":"2016","unstructured":"Yang Y, Liu J, Liang C, Feng L, Fu T, Dong Z, et al. Nanoscale metal-organic particles with rapid clearance for magnetic resonance imaging-guided photothermal therapy. ACS Nano. 2016;16:2774\u201381.","journal-title":"ACS Nano"},{"key":"645_CR29","doi-asserted-by":"publisher","first-page":"115039","DOI":"10.1016\/j.carbpol.2019.115039","volume":"22","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Wang W, Zhao J, Wu C, Ye C, Huang M, et al. Preparation of injectable temperature-sensitive chitosan-based hydrogel for combined hyperthermia and chemotherapy of colon cancer. Carbohydr Polym. 2019;22:115039.","journal-title":"Carbohydr Polym"},{"key":"645_CR30","doi-asserted-by":"publisher","first-page":"122048","DOI":"10.1016\/j.cej.2019.122048","volume":"375","author":"Y Liu","year":"2019","unstructured":"Liu Y, Xi Y, Zhao J, Zhao J, Li J, Huang G, et al. Preparation of therapeutic-laden konjac hydrogel for tumor combination therapy. Chem Eng J. 2019;375:122048.","journal-title":"Chem Eng J"},{"key":"645_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/0885328218796623","volume":"33","author":"M Dowaidar","year":"2018","unstructured":"Dowaidar M, Nasser Abdelhamid H, H\u00e4llbrink M, Langel \u00dc, Zou X. Chitosan enhances gene delivery of oligonucleotide complexes with magnetic nanoparticles\u2013cell-penetrating peptide. J Biomater Appl. 2018;33:392\u2013401.","journal-title":"J Biomater Appl"},{"key":"645_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"M Dowaidar","year":"2017","unstructured":"Dowaidar M, Abdelhamid HN, H\u00e4llbrink M, Freimann K, Kurrikoff K, Zou X, et al. Magnetic nanoparticle assisted self-assembly of cell penetrating peptides-oligonucleotides complexes for gene delivery. Sci Rep. 2017;7:1\u201311.","journal-title":"Sci Rep."},{"key":"645_CR33","first-page":"1","volume":"29","author":"Y Yang","year":"2017","unstructured":"Yang Y, Zhu W, Dong Z, Chao Y, Xu L, Chen M, et al. 1D coordination polymer nanofibers for low-temperature photothermal therapy. Adv Mater. 2017;29:1\u201312.","journal-title":"Adv Mater"},{"key":"645_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biomaterials.2019.03.025","volume":"206","author":"C Ergen","year":"2019","unstructured":"Ergen C, Niemietz PM, Heymann F, Baues M, Gremse F, Pola R, van Bloois L, Storm G, Kiessling F, Trautwein C, Luedde T, Lammers T, Tacke F. Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo. Biomaterials. 2019;206:49\u201360.","journal-title":"Biomaterials"},{"key":"645_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/thno.37301","volume":"10","author":"M Wang","year":"2020","unstructured":"Wang M, Zhang M, Fu L, Lin J, Zhou X, Zhou P, Huang P, Hu H, Han Y. Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis. Theranostics. 2020;10:36.","journal-title":"Theranostics."},{"key":"645_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.apsb.2019.07.003","volume":"10","author":"W Li","year":"2019","unstructured":"Li W, Zhou C, Fu Y, Chen T, Liu X, Zhang Z, Gong T. Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats. Acta Pharm Sin B. 2019;10:693\u2013710.","journal-title":"Acta Pharm Sin B."},{"key":"645_CR37","doi-asserted-by":"publisher","first-page":"119616","DOI":"10.1016\/j.biomaterials.2019.119616","volume":"230","author":"QQ Fan","year":"2020","unstructured":"Fan QQ, Zhang CL, Qiao JB, Cui PF, Xing L, Oh YK, Jiang HL. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy. Biomaterials. 2020;230:119616.","journal-title":"Biomaterials."},{"key":"645_CR38","doi-asserted-by":"publisher","first-page":"3910","DOI":"10.1021\/acsnano.8b06924","volume":"13","author":"J Luo","year":"2019","unstructured":"Luo J, Zhang P, Zhao T, Jia M, Yin P, Li W, et al. Golgi apparatus-targeted chondroitin-modified nanomicelles suppress hepatic stellate cell activation for the management of liver fibrosis. ACS Nano. 2019;13:3910\u201323.","journal-title":"ACS Nano"},{"key":"645_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jconrel.2020.02.049","volume":"321","author":"J Qiao","year":"2020","unstructured":"Qiao J, Fan Q, Zhang C, Lee J, Byun J, Xing L. Hyperbranched lipoid-based lipid nanoparticles for bidirectional regulation of collagen accumulation in liver fi brosis. J Control Release. 2020;321:629\u201340.","journal-title":"J Control Release"},{"key":"645_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jconrel.2019.04.022","volume":"303","author":"Y Li","year":"2019","unstructured":"Li Y, Pu S, Liu Q, Li R, Zhang J, Wu T, et al. An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis. J Control Release. 2019;303:77\u201390.","journal-title":"J Control Release"},{"key":"645_CR41","first-page":"1","volume":"1903138","author":"L Lin","year":"2020","unstructured":"Lin L, Gong H, Li R, Huang J, Cai M, Lan T, et al. Nanodrug with ROS and pH dual-sensitivity ameliorates Liver fibrosis via multicellular regulation. Adv Sci. 2020;1903138:1\u201315.","journal-title":"Adv Sci."},{"key":"645_CR42","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1021\/acsami.7b14004","volume":"10","author":"C Li","year":"2018","unstructured":"Li C, Zhang X, Chen Q, Zhang J, Li W, Hu H, Zhao X, Qiao M, Chen D. Synthetic polymeric mixed micelles targeting lymph nodes trigger enhanced cellular and humoral immune responses. ACS Appl Mater Interfaces. 2018;10:2874\u201389.","journal-title":"ACS Appl Mater Interfaces"},{"key":"645_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.carbpol.2015.10.050","volume":"137","author":"Y Ma","year":"2016","unstructured":"Ma Y, Fan X, Li L. PH-sensitive polymeric micelles formed by doxorubicin conjugated prodrugs for co-delivery of doxorubicin and paclitaxel. Carbohydr Polym. 2016;137:19\u201329.","journal-title":"Carbohydr Polym"},{"key":"645_CR44","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1021\/acs.jafc.8b02698","volume":"66","author":"J Luo","year":"2018","unstructured":"Luo J, Meng X, Su J, Ma H, Wang W, Fang L, et al. Biotin-modified Polylactic-co-Glycolic acid nanoparticles with improved antiproliferative activity of 15,16-Dihydrotanshinone i in human cervical cancer cells. J Agric Food Chem. 2018;66:9219\u201330.","journal-title":"J Agric Food Chem"},{"key":"645_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.biomaterials.2016.06.026","volume":"102","author":"F Li","year":"2016","unstructured":"Li F, Yan H, Wang J, Li C, Wu J, Wu S, Rao S, Gao X, Jin Q. Non-invasively differentiating extent of liver fibrosis by visualizing hepatic integrin \u03b1v\u03b23 expression with an MRI modality in mice. Biomaterials. 2016;102:162\u201374.","journal-title":"Biomaterials"},{"key":"645_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejps.2013.11.017","volume":"52","author":"J Yang","year":"2014","unstructured":"Yang J, Hou Y, Ji G, Song Z, Liu Y, Dai G, Zhang Y, Chen J. Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats. Eur J Pharm Sci. 2014;52:180\u201390.","journal-title":"Eur J Pharm Sci"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-020-00645-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-020-00645-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-020-00645-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T23:39:15Z","timestamp":1623109155000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-020-00645-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1186\/s12951-020-00645-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"86"}}